2-aminoimidazole has been researched along with scopolamine hydrobromide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bojarski, AJ; Bugno, R; Dubiel, K; Hogendorf, A; Hogendorf, AS; Kalinowska-Tłuścik, J; Knutelska, J; Krawczyk, M; Kurczab, R; Lenda, T; Matłoka, M; Moszczyński-Pętkowski, R; Nikiforuk, A; Pieczykolan, J; Pietruś, W; Pilarski, B; Popik, P; Satała, G; Staroń, J; Wieczorek, M; Zajdel, P | 1 |
1 other study(ies) available for 2-aminoimidazole and scopolamine hydrobromide
Article | Year |
---|---|
2-Aminoimidazole-based antagonists of the 5-HT
Topics: Animals; Cells, Cultured; Cognitive Dysfunction; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Hep G2 Cells; Humans; Imidazoles; Male; Models, Molecular; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Scopolamine; Serotonin Antagonists; Structure-Activity Relationship | 2019 |